Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses
General and administrative	$ 3,155,400	$ 2,501,206	$ 5,910,991	$ 5,269,072
Research and development	2,513,089	2,120,051	4,531,690	4,078,765
Depreciation and amortization	86,518	85,502	173,004	154,767
Total operating expenses	5,755,007	4,706,759	10,615,685	9,502,604
Loss from operations	(5,755,007)	(4,706,759)	(10,615,685)	(9,502,604)
Other income (expense)
Change in fair value of warrant liabilities	(233,821)	1,969,922	(183,164)	2,245,891
Change in fair value of investment option liability	(1,082,141)		(962,636)
Change in fair value of derivative liability	714,000	(53,000)	727,000	(53,000)
Interest income (expense)	916	(668)	905	(4,806)
Total other (expense) income	(601,046)	1,916,254	(417,895)	2,188,085
Net loss	(6,356,053)	(2,790,505)	(11,033,580)	(7,314,519)
Less preferred dividends attributable to non-controlling interest	6,712	7,808	19,041	7,808
Less deemed dividends attributable to accretion of embedded derivative at redemption value	36,997	73,994	147,988	73,994
Net loss attributable to shareholders	(6,399,762)	(2,872,307)	(11,200,609)	(7,396,321)
Other comprehensive loss
Foreign currency translation	(11,286)	(281,014)	(9,318)	(192,305)
Comprehensive loss	$ (6,411,048)	$ (3,153,321)	$ (11,209,927)	$ (7,588,626)
Net loss per share - basic	$ (3.04)	$ (2.73)	$ (5.35)	$ (7.78)
Net loss per share - diluted	$ (3.04)	$ (2.73)	$ (5.35)	$ (7.78)
Weighted average shares outstanding, basic	2,107,583	1,053,760	2,093,008	951,193
Weighted average shares outstanding, diluted	2,107,583	1,053,760	2,093,008	951,193